AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...

By beginning a legal battle against AstraZeneca, the vaccine injured and bereaved can no longer be silenced. The fact of this legal battle poses a fundamental question: in circumstances where ...

The story of AstraZeneca's adventures in vaccines and politics is impossible to separate from the background of the man in charge. As one of his competitors put it: "Astra is Pascal's company ...

The announcement comes just as AstraZeneca, whose COVID-19 vaccine made it a household name amid the global pandemic, has ...

AstraZeneca was sued on Aug. 26 in Pennsylvania Eastern District Court over alleged employment discrimination. The court case was brought by the Gold Law Firm on behalf of a former senior user ...

AstraZeneca PLC AZN shares inched down 0.40% to £119.68 Tuesday, on what proved to be an all-around great trading session for ...

Detailed results from one of AstraZeneca's key lung cancer trials released on Monday showed that its experimental precision drug did not significantly improve overall survival results for patients in ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on ...

Users on X reported the change early on Friday, noting that the Facebook app's logo on their mobile devices — typically a white F on a blue background — had changed to a blue F on a black ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of £159.14. Rajan Sharma’s rating is based on ...

This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain. Sign up for the remaining editions here.

LONDON (Reuters) - Detailed results from one of AstraZeneca's key lung cancer trials released on Monday showed that its experimental precision drug did not significantly improve overall survival ...